COCRYSTAL PHARMA, INC. Cash and Cash Equivalents, Period Increase (Decrease)
COCRYSTAL PHARMA, INC. (COCP) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$2.29 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-11-08
- COCRYSTAL PHARMA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$2.11M, a 338.24% decline year-over-year.
- COCRYSTAL PHARMA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $1.90M.
- COCRYSTAL PHARMA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$2.08M, a 315.84% decline year-over-year.
- COCRYSTAL PHARMA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was -$2.27M.
- COCRYSTAL PHARMA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$5.64M, a 206.22% decline from fiscal 2015.
- COCRYSTAL PHARMA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $5.31M, a 80.72% increase from fiscal 2014.
- COCRYSTAL PHARMA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $2.94M.
- COCRYSTAL PHARMA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2013 was -$3.68M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 87 month |
|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | -$2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$210.00K derived: sum of 2 quarters · filed 2017-11-08 | -$2.29M 10-Q · filed 2017-11-08 | -$4.56M derived: sum of 4 quarters · filed 2017-11-08 | |||||
| 2017-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$189.00K 10-Q · filed 2017-08-08 | -$2.46M derived: sum of 3 quarters · filed 2017-08-08 | -$1.57M derived: sum of 4 quarters · filed 2017-11-08 | |||||
| 2017-03-31 | -$2.08M 10-Q · filed 2017-05-10 | -$4.35M derived: sum of 2 quarters · filed 2017-05-10 | -$3.47M derived: sum of 3 quarters · filed 2017-11-08 | -$8.69M derived: sum of 4 quarters · filed 2017-11-08 | |||||
| 2016-12-31 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$1.38M derived: sum of 2 quarters · filed 2017-11-08 | -$6.60M derived: sum of 3 quarters · filed 2017-11-08 | -$5.64M 10-K · filed 2017-03-31 | |||||
| 2016-09-30 | $884.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$4.34M derived: sum of 2 quarters · filed 2017-11-08 | -$3.37M 10-Q · filed 2017-11-08 | -$6.51M derived: sum of 4 quarters · filed 2017-11-08 | |||||
| 2016-06-30 | -$5.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$4.25M 10-Q · filed 2017-08-08 | -$7.39M derived: sum of 3 quarters · filed 2017-08-08 | -$10.76M derived: sum of 4 quarters · filed 2017-08-08 | |||||
| 2016-03-31 | $966.00K 10-Q · filed 2017-05-10 | -$2.17M derived: sum of 2 quarters · filed 2017-05-10 | -$5.54M derived: sum of 3 quarters · filed 2017-05-10 | -$4.01M derived: sum of 4 quarters · filed 2017-05-10 | |||||
| 2015-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$6.50M derived: sum of 2 quarters · filed 2017-03-31 | -$4.98M derived: sum of 3 quarters · filed 2017-03-31 | $5.31M 10-K · filed 2017-03-31 | |||||
| 2015-09-30 | -$3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$1.84M derived: sum of 2 quarters · filed 2016-11-09 | $8.44M 10-Q · filed 2016-11-09 | $9.41M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2015-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $11.81M 10-Q · filed 2016-08-09 | $12.78M derived: sum of 3 quarters · filed 2017-03-31 | $11.71M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2015-03-31 | $10.29M 10-Q · filed 2016-05-10 | $11.25M derived: sum of 2 quarters · filed 2017-03-31 | $10.18M derived: sum of 3 quarters · filed 2017-03-31 | $11.66M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2014-12-31 | $964.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$104.00K derived: sum of 2 quarters · filed 2017-03-31 | $1.37M derived: sum of 3 quarters · filed 2017-03-31 | $2.94M 10-K · filed 2017-03-31 | |||||
| 2014-09-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $407.00K derived: sum of 2 quarters · filed 2015-11-16 | $1.97M 10-Q · filed 2015-11-16 | $1.16M derived: sum of 4 quarters · filed 2015-11-16 | |||||
| 2014-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $3.04M 10-Q · filed 2015-08-14 | $2.23M derived: sum of 3 quarters · filed 2015-08-14 | $1.28M derived: sum of 4 quarters · filed 2015-08-14 | |||||
| 2014-03-31 | $1.56M 10-Q · filed 2015-05-14 | $756.00K derived: sum of 2 quarters · filed 2015-05-14 | -$193.00K derived: sum of 3 quarters · filed 2015-05-14 | -$1.17M derived: sum of 4 quarters · filed 2015-05-14 | $2.60M 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | -$809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$1.76M derived: sum of 2 quarters · filed 2015-03-31 | -$2.73M derived: sum of 3 quarters · filed 2015-03-31 | -$3.68M 10-K · filed 2015-03-31 | $581.37K 10-K · filed 2014-03-31 | ||||
| 2013-09-30 | -$949.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$1.93M derived: sum of 2 quarters · filed 2014-11-14 | -$2.87M 10-Q · filed 2014-11-14 | $467.60K 10-Q · filed 2013-11-18 | -$2.57M derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | -$977.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.93M 10-Q · filed 2014-08-14 | $292.18K 10-Q · filed 2013-08-15 | -$1.62M derived: sum of 3 quarters · filed 2014-08-14 | -$1.71M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | -$948.00K 10-Q · filed 2014-05-15 | $29.83K 10-Q · filed 2013-05-10 | -$641.55K derived: sum of 2 quarters · filed 2014-05-15 | -$733.15K derived: sum of 3 quarters · filed 2014-05-15 | -$635.82K derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | $306.44K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $214.85K derived: sum of 2 quarters · filed 2014-03-31 | $312.18K derived: sum of 3 quarters · filed 2014-03-31 | -$27.27K 10-K · filed 2014-03-31 | -$354.04K 10-K · filed 2013-04-01 | ||||
| 2012-09-30 | -$91.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | $5.74K derived: sum of 2 quarters · filed 2013-11-18 | -$333.71K 10-Q · filed 2013-11-18 | -$699.10K derived: sum of 4 quarters · filed 2013-11-18 | |||||
| 2012-06-30 | $97.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | -$242.12K 10-Q · filed 2013-08-15 | -$607.51K derived: sum of 3 quarters · filed 2013-08-15 | -$1.67M derived: sum of 4 quarters · filed 2013-08-15 | |||||
| 2012-03-31 | -$339.45K 10-Q · filed 2013-05-10 | -$704.84K derived: sum of 2 quarters · filed 2013-05-10 | -$1.76M derived: sum of 3 quarters · filed 2013-05-10 | -$2.16M derived: sum of 4 quarters · filed 2013-05-10 | |||||
| 2011-12-31 | -$365.39K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$1.42M derived: sum of 2 quarters · filed 2013-04-01 | -$1.82M derived: sum of 3 quarters · filed 2013-04-01 | $164.86K 10-K · filed 2013-04-01 | |||||
| 2011-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$1.46M derived: sum of 2 quarters · filed 2012-11-14 | $530.25K 10-Q · filed 2012-11-14 | $650.52K derived: sum of 4 quarters · filed 2012-11-14 | |||||
| 2011-06-30 | -$399.98K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-28 | $1.59M 10-Q/A · filed 2012-09-28 | $1.71M derived: sum of 3 quarters · filed 2012-10-02 | $1.63M derived: sum of 4 quarters · filed 2012-10-02 | |||||
| 2011-03-31 | $1.99M 10-Q/A · filed 2012-10-02 | $2.11M derived: sum of 2 quarters · filed 2012-10-02 | $2.03M derived: sum of 3 quarters · filed 2012-10-02 | ||||||
| 2010-12-31 | $120.27K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $40.52K derived: sum of 2 quarters · filed 2012-04-16 | -$335.93K 10-K · filed 2012-04-16 | ||||||
| 2010-09-30 | -$79.75K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$456.20K 10-Q · filed 2011-11-21 | |||||||
| 2010-06-30 | -$376.45K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |